Gregory J. Atkins

1.2k total citations
29 papers, 988 citations indexed

About

Gregory J. Atkins is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Gregory J. Atkins has authored 29 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 19 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Gregory J. Atkins's work include Mosquito-borne diseases and control (19 papers), Viral Infections and Vectors (17 papers) and Viral Infections and Outbreaks Research (8 papers). Gregory J. Atkins is often cited by papers focused on Mosquito-borne diseases and control (19 papers), Viral Infections and Vectors (17 papers) and Viral Infections and Outbreaks Research (8 papers). Gregory J. Atkins collaborates with scholars based in Ireland, Sweden and United Kingdom. Gregory J. Atkins's co-authors include B. J. Sheahan, Peter Liljeström, Marina N. Fleeton, Peter Berglund, Mathilda Sjöberg, Henrik Garoff, M. Morris-Downes, Gary Rhodes, Suezanne E. Parker and Margaret Chen and has published in prestigious journals such as Nature Biotechnology, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Gregory J. Atkins

29 papers receiving 898 citations

Peers

Countries citing papers authored by Gregory J. Atkins

Since Specialization

Citations

This map shows the geographic impact of Gregory J. Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Atkins more than expected).

Fields of papers citing papers by Gregory J. Atkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Atkins. The network helps show where Gregory J. Atkins may publish in the future.

Co-authorship network of co-authors of Gregory J. Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Atkins. A scholar is included among the top collaborators of Gregory J. Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Atkins. Gregory J. Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular determinants of alphavirus neuropathogenesis in mice 2016 ·Journal of General Virology ·Gregory J. Atkins, B. J. Sheahan	15
2	Therapeutic and prophylactic applications of alphavirus vectors 2008 ·Expert Reviews in Molecular Medicine ·Gregory J. Atkins, Marina N. Fleeton, B. J. Sheahan	69
3	The 5′ untranslated region as a pathogenicity determinant of Semliki Forest virus in mice 2008 ·Virus Genes ·Christopher H. Logue, B. J. Sheahan, Gregory J. Atkins	12
4	Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus 2007 ·Vaccine ·(unknown), Barbara Kelly, Marina N. Fleeton, B. J. Sheahan, Sareen E. Galbraith, Gregory J. Atkins	2
5	Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors 2007 ·Recent Patents on Anti-Cancer Drug Discovery ·Barbara Kelly, Marina N. Fleeton, Gregory J. Atkins	5
6	The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo 2005 ·Oncology Reports ·Lisa M. Greene, Marina N. Fleeton, Jude M. Mulligan, (unknown), B. J. Sheahan, Gregory J. Atkins, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams, Daniela M. Zisterer	18
7	Alphaviruses and their Derived Vectors as Anti-Tumor Agents 2004 ·Current Cancer Drug Targets ·Gregory J. Atkins, James W. Smyth, Marina N. Fleeton, Sareen E. Galbraith, B. J. Sheahan	16
8	Is an Improved Measles-Mumps-Rubella Vaccine Necessary or Feasible? 2003 ·Critical Reviews in Immunology ·Gregory J. Atkins, S. Louise Cosby	4
9	Inhibition of matrix metalloproteinases ameliorates blood–brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection 2003 ·Veterinary Immunology and Immunopathology ·Brian Keogh, B. J. Sheahan, Gregory J. Atkins, Kingston H. G. Mills	11
10	Effect of intranasal administration of semliki forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis 2003 ·Molecular Therapy ·(unknown), M. Morris-Downes, B. J. Sheahan, Gregory J. Atkins	31
11	Induction of apoptosis in BCL‐2‐expressing rat prostate cancer cells using the Semliki Forest virus vector 2001 ·International Journal of Cancer ·(unknown), B. J. Sheahan, Gregory J. Atkins	17
12	Altered p53 Expression in Benign and Malignant Skin Lesions From Renal Transplant Recipients and Immunocompetent Patients With Skin Cancer: Correlation With Human Papillomaviruses? 2001 ·Diagnostic Molecular Pathology ·Darran P. O’Connor, Elaine W. Kay, M. Leader, Gillian Murphy, Gregory J. Atkins, Mohamed Mabruk	21
13	Self‐Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus 2001 ·The Journal of Infectious Diseases ·Marina N. Fleeton, Margaret Chen, Peter Berglund, Gary Rhodes, Suezanne E. Parker, (unknown), Gregory J. Atkins, Peter Liljeström	125
14	Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems 2001 ·Vaccine ·M. Morris-Downes, K. V. Phenix, Joan A. Smyth, B. J. Sheahan, (unknown), (unknown), Peter Liljeström, D. Todd, Gregory J. Atkins	45
15	Formation of Infectious Pancreatic Necrosis Virus–like Particles Following Expression of Segment A by Recombinant Semliki Forest Virus 2001 ·Marine Biotechnology ·(unknown), (unknown), K. V. Phenix, D. Todd, Laurence M. Vaughan, Gregory J. Atkins	15
16	A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model 2001 ·Vaccine ·M. Morris-Downes, B. J. Sheahan, Marina N. Fleeton, Peter Liljeström, H.W. Reid, Gregory J. Atkins	22
17	Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine 2000 ·Journal of General Virology ·Marina N. Fleeton, B. J. Sheahan, Gregory J. Atkins, Peter Liljeström	59
18	Manipulation of the Semliki Forest virus genome and its potential for vaccine construction 1996 ·Molecular Biotechnology ·Gregory J. Atkins, B. J. Sheahan, Peter Liljeström	11
19	Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant Particles 1993 ·Nature Biotechnology ·Peter Berglund, Mathilda Sjöberg, Henrik Garoff, Gregory J. Atkins, B. J. Sheahan, Peter Liljeström	231
20	Two mutations in the envelope glycoprotein E2 of semliki forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice 1991 ·Virology ·(unknown), B. J. Sheahan, Gregory J. Atkins, J M Wahlberg, Antti Salminen, (unknown)	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact